170 related articles for article (PubMed ID: 30334333)
1. NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2.
Zhou XL; Zhu RR; Wu X; Xu H; Li YY; Xu QR; Liu S; Huang H; Xu X; Wan L; Wu QC; Liu JC
J Cell Mol Med; 2019 Jan; 23(1):568-575. PubMed ID: 30334333
[TBL] [Abstract][Full Text] [Related]
2. A PWWP Domain of Histone-Lysine N-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin.
Sankaran SM; Wilkinson AW; Elias JE; Gozani O
J Biol Chem; 2016 Apr; 291(16):8465-74. PubMed ID: 26912663
[TBL] [Abstract][Full Text] [Related]
3. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.
Kuo AJ; Cheung P; Chen K; Zee BM; Kioi M; Lauring J; Xi Y; Park BH; Shi X; Garcia BA; Li W; Gozani O
Mol Cell; 2011 Nov; 44(4):609-20. PubMed ID: 22099308
[TBL] [Abstract][Full Text] [Related]
4. ISWI chromatin remodeling complexes recruit NSD2 and H3K36me2 in pericentromeric heterochromatin.
Goto N; Suke K; Yonezawa N; Nishihara H; Handa T; Sato Y; Kujirai T; Kurumizaka H; Yamagata K; Kimura H
J Cell Biol; 2024 Aug; 223(8):. PubMed ID: 38709169
[TBL] [Abstract][Full Text] [Related]
5. Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.
Huang X; LeDuc RD; Fornelli L; Schunter AJ; Bennett RL; Kelleher NL; Licht JD
J Biol Chem; 2019 Aug; 294(33):12459-12471. PubMed ID: 31248990
[TBL] [Abstract][Full Text] [Related]
6. NSD2 silencing alleviates pulmonary arterial hypertension by inhibiting trehalose metabolism and autophagy.
Zhou XL; Liu ZB; Zhu RR; Huang H; Xu QR; Xu H; Zeng L; Li YY; Huang CH; Wu QC; Liu JC
Clin Sci (Lond); 2019 May; 133(9):1085-1096. PubMed ID: 31040165
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of the regulation of the normal and oncogenic methylation of nucleosomal histone H3 Lys36 by NSD2.
Sato K; Kumar A; Hamada K; Okada C; Oguni A; Machiyama A; Sakuraba S; Nishizawa T; Nureki O; Kono H; Ogata K; Sengoku T
Nat Commun; 2021 Nov; 12(1):6605. PubMed ID: 34782608
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes.
Wang J; Duan Z; Nugent Z; Zou JX; Borowsky AD; Zhang Y; Tepper CG; Li JJ; Fiehn O; Xu J; Kung HJ; Murphy LC; Chen HW
Cancer Lett; 2016 Aug; 378(2):69-79. PubMed ID: 27164560
[TBL] [Abstract][Full Text] [Related]
9. H3K36me2 methyltransferase NSD2 orchestrates epigenetic reprogramming during spermatogenesis.
Li Z; Zhang X; Xie S; Liu X; Fei C; Huang X; Tang Y; Zhou LQ
Nucleic Acids Res; 2022 Jul; 50(12):6786-6800. PubMed ID: 35736136
[TBL] [Abstract][Full Text] [Related]
10. NSD2 is downregulated in T2DM and promotes β cell proliferation and insulin secretion through the transcriptionally regulation of PDX1.
Shi S; Zhao L; Zheng L
Mol Med Rep; 2018 Sep; 18(3):3513-3520. PubMed ID: 30066931
[TBL] [Abstract][Full Text] [Related]
11. NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis.
Sengupta D; Zeng L; Li Y; Hausmann S; Ghosh D; Yuan G; Nguyen TN; Lyu R; Caporicci M; Morales Benitez A; Coles GL; Kharchenko V; Czaban I; Azhibek D; Fischle W; Jaremko M; Wistuba II; Sage J; Jaremko Ł; Li W; Mazur PK; Gozani O
Mol Cell; 2021 Nov; 81(21):4481-4492.e9. PubMed ID: 34555356
[TBL] [Abstract][Full Text] [Related]
12. Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer.
Zhao LH; Li Q; Huang ZJ; Sun MX; Lu JJ; Zhang XH; Li G; Wu F
Cell Death Dis; 2021 Oct; 12(11):974. PubMed ID: 34671018
[TBL] [Abstract][Full Text] [Related]
13. Histone methyltransferase Nsd2 is required for follicular helper T cell differentiation.
Long X; Zhang L; Zhang Y; Min M; Lin B; Chen J; Ma X; Zhai S; Cai Z; Liu Y; Lu Y; Che N; Tan W; Qin J; Wang X
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31636135
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2.
Hanley RP; Nie DY; Tabor JR; Li F; Sobh A; Xu C; Barker NK; Dilworth D; Hajian T; Gibson E; Szewczyk MM; Brown PJ; Barsyte-Lovejoy D; Herring LE; Wang GG; Licht JD; Vedadi M; Arrowsmith CH; James LI
J Am Chem Soc; 2023 Apr; 145(14):8176-8188. PubMed ID: 36976643
[TBL] [Abstract][Full Text] [Related]
15. Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma.
He C; Liu C; Wang L; Sun Y; Jiang Y; Hao Y
Cell Death Dis; 2019 Jan; 10(2):65. PubMed ID: 30683853
[TBL] [Abstract][Full Text] [Related]
16. NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-β/TGF-βRI/SMADs signaling.
Zhu L; Yu CL; Zheng Y
Biochem Biophys Res Commun; 2019 Nov; 519(3):489-496. PubMed ID: 31526565
[TBL] [Abstract][Full Text] [Related]
17. Depletion of Nsd2-mediated histone H3K36 methylation impairs adipose tissue development and function.
Zhuang L; Jang Y; Park YK; Lee JE; Jain S; Froimchuk E; Broun A; Liu C; Gavrilova O; Ge K
Nat Commun; 2018 May; 9(1):1796. PubMed ID: 29728617
[TBL] [Abstract][Full Text] [Related]
18. The interaction of histone modification related H3F3B and NSD2 genes increases the susceptibility to schizophrenia in a Chinese population.
Liu W; Fang Y; Shi Y; Cheng Y; Sun C; Cui D
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109918. PubMed ID: 32169559
[TBL] [Abstract][Full Text] [Related]
19. Decreased NSD2 impairs stromal cell proliferation in human endometrium via reprogramming H3K36me2.
Qin CM; Wei XW; Wu JY; Liu XQ; Lin Y
Reproduction; 2024 Mar; 167(3):. PubMed ID: 38236723
[TBL] [Abstract][Full Text] [Related]
20. NSD2 as a Promising Target in Hematological Disorders.
Azagra A; Cobaleda C
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
